Prognostic importance of BCL6 rearrangements in diffuse large B-cell lymphoma with respect to Bcl6 protein levels and primary lymphoma site

Human Pathology

Volumn 40, Issue 7, 2009, Pages 1055-1056

  Tzankov, Alexandar ^a   Schneider, Aurelia ^a   Hoeller, Sylvia ^a   Dirnhofer, Stephan ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BCL 6;

B CELL LYMPHOMA; CANCER SURVIVAL; FLUORESCENCE IN SITU HYBRIDIZATION; GENE REARRANGEMENT; GENE SILENCING; GENE TRANSLOCATION; HUMAN; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; LETTER; PROGNOSIS; PROTEIN EXPRESSION; TISSUE MICROARRAY;

DNA-BINDING PROTEINS; GENE REARRANGEMENT; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; PROGNOSIS;

EID: 66549127133     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2009.03.008     Document Type: Letter

References (5)

1. Tibiletti M.G., Martin V., Bernasconi B., et al. BCL2, BCL6, MYC, MALT 1, and BCL10 rearrangements in nodal diffuse large B-cell lymphomas: a multicenter evaluation of a new set of fluorescent in situ hybridization probes and correlation with clinical outcome. Hum Pathol (2009) [published online]
2. Tzankov A., Meier C., Hirschmann P., Went P., Pileri S.A., and Dirnhofer S. Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma. Haematologica 93 (2008) 193-200
3. Barrans S.L., O'Connor S.J., Evans P.A., et al. Rearrangement of the BCL6 locus at 3q27 is an independent poor prognostic factor in nodal diffuse large B-cell lymphoma. Br J Haematol 117 (2002) 322-332
4. Jerkeman M., Aman P., Cavallin-Stahl E., et al. Prognostic implications of BCL6 rearrangement in uniformly treated patients with diffuse large B-cell lymphoma-a Nordic Lymphoma Group study. Int J Oncol 20 (2002) 161-165
5. Ohno H. Pathogenetic and clinical implications of non-immunoglobulin; BCL6 translocations in B-cell non-Hodgkin's lymphoma. J Clin Exp Hematop 46 (2006) 43-53